VLA1553, commercially known as Ixchiq, has received USFDA clearance and will be launched in India — which has seen high number of chikungunya cases — after ‘regulatory talks with DCGI’.
Trial of live-attenuated vaccine VLA1553 was conducted in US, with high seroprotection rates observed in participants up to 180 days after vaccination. Study published in 'The Lancet'.
Trials for the vaccine, which International Vaccine Institute is developing in partnership with Bharat Biotech, are also expected to begin in Panama and Colombia by September.
Researchers from Chulalongkorn University in Thailand find that chikungunya strain identified in Thailand has mutations that originated in India and Bangladesh
From Indian-origin people being kicked out of Uganda overnight to facing racism in Canada and the UK today, these instances offer lessons for the Indian diaspora.
As many as 21 policy reforms are under implementation following Invest Kerala Global Summit, as LDF govt works to change perception that the state is not conducive to businesses.
Company builds microsatellites that are smaller, faster, cheaper to produce. ICEYE will develop & launch micro-satellites, hand them over to India, which will have full control & sovereignty.
What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.
COMMENTS